93 related articles for article (PubMed ID: 22228611)
1. Enhanced intracellular delivery and multi-target gene silencing triggered by tripodal RNA structures.
Chang CI; Lee TY; Kim S; Sun X; Hong SW; Yoo JW; Dua P; Kang HS; Kim S; Li CJ; Lee DK
J Gene Med; 2012 Feb; 14(2):138-46. PubMed ID: 22228611
[TBL] [Abstract][Full Text] [Related]
2. Efficient intracellular delivery and multiple-target gene silencing triggered by tripodal RNA based nanoparticles: a promising approach in liver-specific RNAi delivery.
Sajeesh S; Lee TY; Kim JK; Son DS; Hong SW; Kim S; Yun WS; Kim S; Chang C; Li C; Lee DK
J Control Release; 2014 Dec; 196():28-36. PubMed ID: 25251899
[TBL] [Abstract][Full Text] [Related]
3. Nonviral in vivo delivery of therapeutic small interfering RNAs.
Aigner A
Curr Opin Mol Ther; 2007 Aug; 9(4):345-52. PubMed ID: 17694447
[TBL] [Abstract][Full Text] [Related]
4. Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung.
Günther M; Lipka J; Malek A; Gutsch D; Kreyling W; Aigner A
Eur J Pharm Biopharm; 2011 Apr; 77(3):438-49. PubMed ID: 21093588
[TBL] [Abstract][Full Text] [Related]
5. In vivo gene silencing in solid tumors by targeted electrically mediated siRNA delivery.
Golzio M; Mazzolini L; Ledoux A; Paganin A; Izard M; Hellaudais L; Bieth A; Pillaire MJ; Cazaux C; Hoffmann JS; Couderc B; Teissié J
Gene Ther; 2007 May; 14(9):752-9. PubMed ID: 17344906
[TBL] [Abstract][Full Text] [Related]
6. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.
Aigner A
J Biotechnol; 2006 Jun; 124(1):12-25. PubMed ID: 16413079
[TBL] [Abstract][Full Text] [Related]
7. Barriers to successful delivery of short interfering RNA after systemic administration.
White PJ
Clin Exp Pharmacol Physiol; 2008 Nov; 35(11):1371-6. PubMed ID: 18565190
[TBL] [Abstract][Full Text] [Related]
8. Nonviral genetic modification mediates effective transgene expression and functional RNA interference in human mesenchymal stem cells.
Hoelters J; Ciccarella M; Drechsel M; Geissler C; Gülkan H; Böcker W; Schieker M; Jochum M; Neth P
J Gene Med; 2005 Jun; 7(6):718-28. PubMed ID: 15712343
[TBL] [Abstract][Full Text] [Related]
9. Targeted lipoplexes for siRNA delivery.
Cardoso A; Trabulo S; Moreira JN; Düzgüneş N; de Lima MC
Methods Enzymol; 2009; 465():267-87. PubMed ID: 19913172
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of adenovirus infections by siRNA-mediated silencing of early and late adenoviral gene functions.
Eckstein A; Grössl T; Geisler A; Wang X; Pinkert S; Pozzuto T; Schwer C; Kurreck J; Weger S; Vetter R; Poller W; Fechner H
Antiviral Res; 2010 Oct; 88(1):86-94. PubMed ID: 20708037
[TBL] [Abstract][Full Text] [Related]
11. Sequence-specific gene silencing in murine muscle induced by electroporation-mediated transfer of short interfering RNA.
Kishida T; Asada H; Gojo S; Ohashi S; Shin-Ya M; Yasutomi K; Terauchi R; Takahashi KA; Kubo T; Imanishi J; Mazda O
J Gene Med; 2004 Jan; 6(1):105-10. PubMed ID: 14716682
[TBL] [Abstract][Full Text] [Related]
12. Quantification of siRNAs in vitro and in vivo.
Cheng A; Vlassov AV; Magdaleno S
Methods Mol Biol; 2011; 764():183-97. PubMed ID: 21748641
[TBL] [Abstract][Full Text] [Related]
13. Intracellular siRNA and precursor miRNA trafficking using bioresponsive copolypeptides.
Rahbek UL; Howard KA; Oupicky D; Manickam DS; Dong M; Nielsen AF; Hansen TB; Besenbacher F; Kjems J
J Gene Med; 2008 Jan; 10(1):81-93. PubMed ID: 18000993
[TBL] [Abstract][Full Text] [Related]
14. Dual gene targeted multimeric siRNA for combinatorial gene silencing.
Lee SH; Mok H; Jo S; Hong CA; Park TG
Biomaterials; 2011 Mar; 32(9):2359-68. PubMed ID: 21183215
[TBL] [Abstract][Full Text] [Related]
15. Effects of treatment with small interfering RNA on joint inflammation in mice with collagen-induced arthritis.
Schiffelers RM; Xu J; Storm G; Woodle MC; Scaria PV
Arthritis Rheum; 2005 Apr; 52(4):1314-8. PubMed ID: 15818667
[TBL] [Abstract][Full Text] [Related]
16. Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy.
Kim DH; Behlke MA; Rose SD; Chang MS; Choi S; Rossi JJ
Nat Biotechnol; 2005 Feb; 23(2):222-6. PubMed ID: 15619617
[TBL] [Abstract][Full Text] [Related]
17. Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model.
Reich SJ; Fosnot J; Kuroki A; Tang W; Yang X; Maguire AM; Bennett J; Tolentino MJ
Mol Vis; 2003 May; 9():210-6. PubMed ID: 12789138
[TBL] [Abstract][Full Text] [Related]
18. Choice of the adequate detection time for the accurate evaluation of the efficiency of siRNA-induced gene silencing.
Choi I; Cho BR; Kim D; Miyagawa S; Kubo T; Kim JY; Park CG; Hwang WS; Lee JS; Ahn C
J Biotechnol; 2005 Nov; 120(3):251-61. PubMed ID: 16095743
[TBL] [Abstract][Full Text] [Related]
19. RNA interference for the identification of disease-associated genes.
Nencioni A; Sandy P; Dillon C; Kissler S; Blume-Jensen P; Van Parijs L
Curr Opin Mol Ther; 2004 Apr; 6(2):136-40. PubMed ID: 15195924
[TBL] [Abstract][Full Text] [Related]
20. RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo.
Urban-Klein B; Werth S; Abuharbeid S; Czubayko F; Aigner A
Gene Ther; 2005 Mar; 12(5):461-6. PubMed ID: 15616603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
